Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -19160.00% is 154% below its 5-year average of -7555.32%, near the high end of its 5-year range (-562900.00%–0.00%).
90.91% above its 12-month average of -210873.01%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -366468.18%.
OPERATING MARGIN
-19160.00%
OPERATING MARGIN AVG TTM
-210873.01%
OPERATING MARGIN AVG 3Y
-6832.27%
OPERATING MARGIN AVG 5Y
-7555.32%
OPERATING MARGIN AVG 10Y
-3332.35%
OPERATING MARGIN AVG 15Y
-2347.70%
OPERATING MARGIN AVG 20Y
-1647.55%
CURRENT VS TTM AVG
+90.91%
CURRENT VS 3Y AVG
-180.43%
CURRENT VS 5Y AVG
-153.60%
CURRENT VS 10Y AVG
-474.97%
CURRENT VS 15Y AVG
-716.12%
CURRENT VS 20Y AVG
-1062.94%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 553 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Celldex Therapeutics, Inc.
Market Cap
$2.12B
Operating Margin
-19160.00%
TTM Avg
-210873.01%
3Y Avg
-6832.27%
5Y Avg
-7555.32%
Market Cap
$2.12B
Operating Margin
10.04%
TTM Avg
9.32%
3Y Avg
8.61%
5Y Avg
7.98%
Market Cap
$2.17B
Operating Margin
0.41%
TTM Avg
-3.56%
3Y Avg
0.15%
5Y Avg
-1.31%
Market Cap
$2.04B
Operating Margin
38.98%
TTM Avg
19.21%
3Y Avg
-11.92%
5Y Avg
-190.31%
Market Cap
$2.04B
Operating Margin
6.02%
TTM Avg
5.04%
3Y Avg
-2.01%
5Y Avg
-12.30%
Market Cap
$2.03B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.01B
Operating Margin
37.06%
TTM Avg
17.54%
3Y Avg
-25.09%
5Y Avg
-117.46%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | $2.12B | -19160.00% | -210873.01% | -6832.27% | -7555.32% |
| Addus HomeCare Corporation (ADUS)vs › | $2.12B | 10.04% | 9.32% | 8.61% | 7.98% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.17B | 0.41% | -3.56% | 0.15% | -1.31% |
| Alvotech (ALVO)vs › | $2.07B | 9.62% | 13.78% | -194.45% | -270.76% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.04B | 38.98% | 19.21% | -11.92% | -190.31% |
| Azenta, Inc. (AZTA)vs › | $2.03B | -3.49% | -3.57% | -5.95% | -5.03% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.04B | 6.02% | 5.04% | -2.01% | -12.30% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $2.03B | 0.00% | 0.00% | 0.00% | 0.00% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.01B | 37.06% | 17.54% | -25.09% | -117.46% |
| AxoGen, Inc. (AXGN)vs › | $2.00B | -5.12% | -2.62% | -10.04% | -13.46% |
Gross Margin
100.0%
Operating Margin
-19160.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -366468.18% |
| 2026-03-31 | -562900.00% |
| 2025-12-31 | -116249.33% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | -8747.53% |
| 2025-03-31 | -9027.19% |
| 2024-12-31 | -4768.26% |
| 2024-09-30 | -1633.53% |
| 2024-06-30 | -1854.16% |
| 2024-03-31 | -26030.77% |
| 2023-12-31 | -1152.92% |
| 2023-09-30 | -2718.46% |
| 2023-06-30 | -12389.93% |
| 2023-03-31 | -3357.91% |
| 2022-12-31 | -1728.77% |
| 2022-09-30 | -6804.91% |
| 2022-06-30 | -22328.83% |
| 2022-03-31 | -13366.09% |
| 2021-12-31 | -6089.82% |
| 2021-09-30 | -13610.46% |
| 2021-06-30 | -386.21% |
| 2021-03-31 | -2429.05% |
| 2020-12-31 | -654.72% |
| 2020-09-30 | -2147.01% |
| 2020-06-30 | -4815.68% |
| 2020-03-31 | -471.66% |
| 2019-12-31 | -1464.37% |
| 2019-09-30 | -2169.23% |
| 2019-06-30 | -1714.27% |
| 2019-03-31 | -1259.02% |
| 2018-12-31 | -687.19% |
| 2018-09-30 | -825.08% |
| 2018-06-30 | -610.68% |
| 2018-03-31 | -2941.91% |
| 2017-12-31 | -738.60% |
| 2017-09-30 | -814.50% |
| 2017-06-30 | -755.50% |
| 2017-03-31 | -2288.92% |
| 2016-12-31 | -1859.77% |
| 2016-09-30 | -1351.04% |
| 2016-06-30 | -2330.17% |
| 2016-03-31 | -2740.14% |
| 2015-12-31 | -1868.04% |
| 2015-09-30 | -3155.07% |
| 2015-06-30 | -1503.67% |
| 2015-03-31 | -6374.69% |
| 2014-12-31 | -2170.01% |
| 2014-09-30 | -2755.86% |
| 2014-06-30 | -4822.47% |
| 2014-03-31 | -7569.47% |
| 2013-12-31 | -3566.77% |
| 2013-09-30 | -2374.39% |
| 2013-06-30 | -19235.05% |
| 2013-03-31 | -720.84% |
| 2012-12-31 | -453.80% |
| 2012-09-30 | -473.85% |
| 2012-06-30 | -671.38% |
| 2012-03-31 | -546.16% |
| 2011-12-31 | 1276.38% |
| 2011-09-30 | -485.74% |
| 2011-06-30 | -506.20% |
| 2011-03-31 | -383.86% |
| 2010-12-31 | 73.09% |
| 2010-09-30 | -368.73% |
| 2010-06-30 | -314.67% |
| 2010-03-31 | -253.35% |
| 2009-12-31 | 500.01% |
| 2009-09-30 | -177.57% |
| 2009-06-30 | -324.88% |
| 2009-03-31 | -208.66% |
| 2008-12-31 | 389.81% |
| 2008-09-30 | -363.76% |
| 2008-06-30 | -528.12% |
| 2008-03-31 | -15045.62% |
| 2007-12-31 | -314.61% |
| 2007-09-30 | -1553.04% |
| 2007-06-30 | -281.29% |
| 2007-03-31 | -355.54% |
| 2006-12-31 | -1846.32% |
| 2006-09-30 | -1812.65% |
| 2006-06-30 | -1251.17% |
| 2006-03-31 | -77.69% |
| 2005-12-31 | 2299.75% |
| 2005-09-30 | -551.10% |
| 2005-06-30 | -769.62% |
| 2005-03-31 | -517.19% |
| 2004-12-31 | -158.19% |
| 2004-09-30 | -723.58% |
| 2004-06-30 | -447.18% |
| 2004-03-31 | -64.78% |
| 2003-12-31 | -336.56% |
| 2003-09-30 | -107.56% |
| 2003-06-30 | -296.32% |
| 2003-03-31 | -511.12% |
| 2002-12-31 | -442.81% |
| 2002-09-30 | -8.72% |
